76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Myomo Inc
Closed
1.98 -3.41
Overview
Share price change
24h
Min
1.96
Max
2.03
Income | -3.2M -3.5M |
|---|---|
Sales | -2.2M 9.8M |
Profit margin | -35.243 |
Employees | 184 |
EBITDA | -3.7M -3.5M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +324.39% upside |
Next Earnings | 5 Aug 2025 |
|---|
Market Cap | -101M 74M |
|---|---|
Previous open | 5.39 |
Previous close | 1.98 |
Myomo Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Myomo Inc Forecast
Price Target
By TipRanks
324.39% upside
12 Months Forecast
Average 8.7 USD 324.39%
High 11.5 USD
Low 6.5 USD
Based on 5 Wall Street analysts offering 12 month price targets forMyomo Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
